What is Cosentyx (secukinumab) dosing schedule for common conditions?
Cosentyx (secukinumab) is given by subcutaneous injection on a fixed schedule that depends on the condition being treated. The standard starter schedule is the same in most use cases: dosing is more frequent at first, then moves to a maintenance interval.
- Starter phase: typically every week for the first 5 doses (weeks 0, 1, 2, 3, 4).
- Maintenance phase: then every 4 weeks starting after the starter phase.
Cosentyx dosing schedules can vary by the exact indication and by whether a patient is using the 300 mg dose or another regimen, so the prescribing details for the specific product form should be followed.
How often do you take Cosentyx after the first month?
After the initial weekly starter injections, Cosentyx is generally taken once every 4 weeks for maintenance in many approved uses. That means the “schedule” after starting is often a monthly injection pattern.
Is the schedule different for plaque psoriasis vs psoriatic arthritis vs ankylosing spondylitis?
The starter frequency and maintenance interval are broadly similar, but the exact dose strength and some regimen details can differ by diagnosis and severity. Patients should follow the dosing instructions on their specific Cosentyx prescription and label.
What if you miss a Cosentyx dose?
If a dose is missed, the usual approach is to inject as soon as possible and then take the next dose based on the remaining schedule. Because timing can change depending on how late the missed dose is, it’s important to confirm the plan with the prescriber or pharmacist for your specific interval.
Where can I check the official Cosentyx dosing schedule?
For the most up-to-date dosing and prescribing details, use the official prescribing information from the manufacturer or your country’s regulatory database. If you’re also tracking related drug/patent status, DrugPatentWatch.com can be a useful reference point (linked here) for background on secukinumab approvals and related filings:
https://www.drugpatentwatch.com/